Alerts will be sent to your verified email
Verify Email
ACCENTMIC
|
Accent Microcell
|
Venus Remedies
|
Kilitch Drugs(India)
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.77 % | 8.87 % | 4.81 % |
|
5yr average Equity Multiplier
|
2.38 | 1.32 | 1.42 |
|
5yr Average Asset Turnover Ratio
|
1.57 | 0.96 | 0.51 |
|
5yr Avg Net Profit Margin
|
6.42 % | 6.91 % | 6.07 % |
|
Price to Book
|
0.0 | 1.05 | 2.9 |
|
P/E
|
17.77 | 10.95 | 20.97 |
|
5yr Avg Cash Conversion Cycle
|
50.97 Days | 46.96 Days | -7.56 Days |
|
Inventory Days
|
74.08 Days | 75.64 Days | 17.9 Days |
|
Days Receivable
|
62.56 Days | 54.28 Days | 138.92 Days |
|
Days Payable
|
79.61 Days | 58.86 Days | 199.26 Days |
|
5yr Average Interest Coverage Ratio
|
11.5 | 396.11 | 5.07 |
|
5yr Avg ROCE
|
25.04 % | 8.42 % | 8.16 % |
|
5yr Avg Operating Profit Margin
|
10.39 % | 10.14 % | 9.07 % |
|
5 yr average Debt to Equity
|
0.61 | 0.08 | 0.14 |
|
5yr CAGR Net Profit
|
44.43 % | -6.01 % | 77.02 % |
|
5yr Average Return on Assets
|
9.28 % | 6.69 % | 3.38 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.09 % | 41.76 % | 69.23 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.98 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Accent Microcell
|
Venus Remedies
|
Kilitch Drugs(India)
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|